Nifensar XL en es it fr

Nifensar XL Brand names, Nifensar XL Analogs

Nifensar XL Brand Names Mixture

  • No information avaliable

Nifensar XL Chemical_Formula


Nifensar XL RX_link

Nifensar XL fda sheet

Nifensar_XL FDA

Nifensar XL msds (material safety sheet)

Nifensar_XL MSDS

Nifensar XL Synthesis Reference

Bossert, Vater, U.S. Pat. 3,485,847 (1969)

Nifensar XL Molecular Weight

346.335 g/mol

Nifensar XL Melting Point

172 - 174 oC

Nifensar XL H2O Solubility


Nifensar XL State


Nifensar XL LogP


Nifensar XL Dosage Forms

Capsule; Tablet; Tablet (extended-release)

Nifensar XL Indication

For the management of vasospastic angina, chronic stable angina and hypertension.

Nifensar XL Pharmacology

Nifedipine, the prototype of the dihydropyridine class of calcium-channel antagonists, is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nifedipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.

Nifensar XL Absorption

Rapidly and fully absorbed following oral administration.

Nifensar XL side effects and Toxicity

Symptoms of overdose include dizziness, drowsiness, nausea, severe drop in blood pressure, slurred speech, and weakness. LD50=494 mg/kg (orally in mice); LD50=1022 mg/kg (orally in rats)

Nifensar XL Patient Information

Nifensar XL Organisms Affected

Humans and other mammals